Relationship between adiponectin, obesity and insulin resistance
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Objectives: the conditions of obesity and overweight pose a major risk for a number of comorbidities, including clinical syndromes resulting from atherosclerotic disease. Recent studies strongly indicate that adipose tissue is an active endocrine organ that secretes bioactive factors such as adipokines. Adiponectin appears to have a regulatory role in the mechanism of insulin resistance and in the development of atherosclerosis. This systematic review aims to evaluate the anti-atherogenic effects of adiponectin and its properties to improve and mimic metabolic and vascular actions of insulin and its influence on endothelial function. Methods: a qualitative, exploratory and literature review was performed in the PubMed, Portal Capes and Scielo databases using as key-words "adiponectin", "obesity", "insulin resistance", "anti-inflammatory", "therapeutic strategies" and "future prospects". Results: evidence suggests that adiponectin has anti-atherogenic properties with anti-inflammatory effects on the vascular wall. Moreover, it modifies the vascular intracellular signaling and has indirect antioxidant effects on the human myocardium. On the other hand, there are studies suggesting that increased levels of adiponectin are paradoxically associated with a worse prognosis in heart failure syndrome, although the mechanisms are not clear. Conclusion: it is not clear whether adiponectin levels have any clinical significance for risk stratification in cardiovascular disease or if they simply reflect the activation of complex underlying mechanisms. Changes in lifestyle and some drug treatments for hypertension and coronary heart disease have shown significant effect to increase adiponectin levels, and simultaneously decrease in insulin resistance and endothelial dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652
The cellular and signaling networks linking the immune system and metabolism in disease
Osborn, O., & Olefsky, J. M. (2012) · Nature Medicine · doi:10.1038/nm.2627 · Cited by 1,551
Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T., et al. (2007) · Nature Medicine · doi:10.1038/nm1557 · Cited by 1,396
Inflammatory cytokines in vascular dysfunction and vascular disease
Sprague, A. H., & Khalil, R. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.029 · Cited by 1,352
Adiponectin and AdipoR1 Regulate PGC-1α and Mitochondria by Ca2+ and AMPK/SIRT1
Iwabu, M., Yamauchi, T., Okada-Iwabu, M., Sato, K., Nakagawa, T., Funata, M., Yamaguchi, M., Namiki, S., Nakayama, R., Tabata, M., et al. (2010) · Nature · doi:10.1038/nature08991 · Cited by 971
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892
Bruun, J. M., Lihn, A. S., Verdich, C., Pedersen, S. B., Toubro, S., Astrup, A., & Richelsen, B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00110.2003 · Cited by 775
Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation
Fu, Y., Luo, N., Klein, R. L., & Garvey, W. T. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400373-jlr200 · Cited by 666
Adiponectin: mechanistic insights and clinical implications
Turer, A. T., & Scherer, P. E. (2012) · Diabetologia · doi:10.1007/s00125-012-2598-x · Cited by 632
Stefan, N., Vozarova, B., Funahashi, T., Matsuzawa, Y., Weyer, C., Lindsay, R. S., Youngren, J. F., Havel, P. J., Pratley, R. E., Bogardus, C., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1884 · Cited by 558
Leptin and Cardiovascular Disease: Response to Therapeutic Interventions
Koh, K. K., Park, S. M., & Quon, M. J. (2008) · Circulation · doi:10.1161/circulationaha.107.741645 · Cited by 479
Endothelial Dysfunction in Obesity and Insulin Resistance: A Road to Diabetes and Heart Disease
Caballero, A. E. (2003) · Obesity Research · doi:10.1038/oby.2003.174 · Cited by 416
Chemokines control fat accumulation and leptin secretion by cultured human adipocytes
Gerhardt, C. C., Romero, I. A., Cancello, R., Camoin, L., & Strosberg, A. D. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00394-x · Cited by 345
Adiponectin actions in the cardiovascular system
HOPKINS, T., OUCHI, N., SHIBATA, R., & WALSH, K. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.009 · Cited by 327
Diabesity: an overview of a rising epidemic
Farag, Y. M. K., & Gaballa, M. R. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq576 · Cited by 320
Lara-Castro, C., Fu, Y., Chung, B. H., & Garvey, W. T. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32814a645f · Cited by 315
Adiponectin in health and disease
Oh, D. K., Ciaraldi, T., & Henry, R. R. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00610.x · Cited by 287
Bacha, F., Saad, R., Gungor, N., & Arslanian, S. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.547 · Cited by 278
Awazawa, M., Ueki, K., Inabe, K., Yamauchi, T., Kubota, N., Kaneko, K., Kobayashi, M., Iwane, A., Sasako, T., Okazaki, Y., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.010 · Cited by 277
Adiponectin and Cardiovascular Disease
Han, S. H., Quon, M. J., Kim, J.-A., & Koh, K. K. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.061 · Cited by 276
Gordura visceral e síndrome metabólica: mais que uma simples associação
Filho, F. F. R., Mariosa, L. S. S., Ferreira, S. R. G., & Zanella, M. T. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000200009 · Cited by 268
Adiponectin: from obesity to cardiovascular disease
Antoniades, C., Antonopoulos, A. S., Tousoulis, D., & Stefanadis, C. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00571.x · Cited by 219
Cavusoglu, E. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl153 · Cited by 208
Circulating adiponectin concentrations in patients with congestive heart failure
George, J., Patal, S., Wexler, D., Sharabi, Y., Peleg, E., Kamari, Y., Grossman, E., Sheps, D., Keren, G., & Roth, A. (2006) · Heart · doi:10.1136/hrt.2005.083345 · Cited by 204
Frystyk, J., Berne, C., Berglund, L., Jensevik, K., Flyvbjerg, A., & Zethelius, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1067 · Cited by 201
Chen, M. B., McAinch, A. J., Macaulay, S. L., Castelli, L. A., O’Brien, P. E., Dixon, J. B., Cameron-Smith, D., Kemp, B. E., & Steinberg, G. R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1980 · Cited by 200
O'Rourke, R. W., Metcalf, M. D., White, A. E., Madala, A., Winters, B. R., Maizlin, I. I., Jobe, B. A., Roberts, C. T., Slifka, M. K., & Marks, D. L. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.133 · Cited by 196
Citocinas, disfunção endotelial e resistência à insulina
de Carvalho, M. H. C., Colaço, A. L., & Fortes, Z. B. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000200016 · Cited by 180
The link between obesity and albuminuria: adiponectin and podocyte dysfunction
Sharma, K. (2009) · Kidney International · doi:10.1038/ki.2009.137 · Cited by 168
Debard, C., Laville, M., Berbe, V., Loizon, E., Guillet, C., Morio, B., Boirie, Y., & Vidal, H. (2004) · Diabetologia · doi:10.1007/s00125-004-1394-7 · Cited by 163
McEntegart, M. B., Awede, B., Petrie, M. C., Sattar, N., Dunn, F. G., MacFarlane, N. G., & McMurray, J. J. V. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm033 · Cited by 157
Adiponectin, obesity, and cardiovascular disease
Faßhauer, M., Paschke, R., & Stümvoll, M. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.016 · Cited by 138 · cited 2×
“Source: Fasshauer et al., 2004.25 78 rev assoC Med bras 2015; 61(1):72-80 ity in patients with high blood pressure (hypertension without glucose tolerance, with poor glycemic control) in the included trials.”
BackgroundInfluentialThe role of adiponectin in human vascular physiology
Vaiopoulos, G., Marinou, K., Christodoulides, C., & Koutsilieris, M. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.07.047 · Cited by 115
Sell, H., Dietze‐Schroeder, D., Eckardt, K., & Eckel, J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.010 · Cited by 89
Nakamura, T., Funayama, H., Kubo, N., Yasu, T., Kawakami, M., Saito, M., Momomura, S.-I., & Ishikawa, S.-E. (2006) · Circulation Journal · doi:10.1253/circj.70.1557 · Cited by 84
Tentolouris, C. A., Tousoulis, D., Antoniades, C. A., Bosinakou, E., Kotsopoulou, M., Trikas, A. G., TOUTOUZAS, P. K., & Stefanadis, C. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.08.002 · Cited by 84
Oligomerization state-dependent elevations of adiponectin in chronic daily headache
Peterlin, B. L., Alexander, G. M., Tabby, D. S., & Reichenberger, E. R. (2008) · Neurology · doi:10.1212/01.wnl.0000312278.40250.6e · Cited by 70
Lack of association between body mass index and plasma adiponectin levels in healthy adults
Kuo, S.-M., & Halpern, M. M. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.20 · Cited by 69
Obesity and disease activity in juvenile idiopathic arthritis
Pelajo, C. F., Lopez‐Benitez, J. M., & Miller, L. C. (2012) · Pediatric Rheumatology · doi:10.1186/1546-0096-10-3 · Cited by 46 · cited 1×
“Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2) and AMPK/SIRT1.”
BackgroundLi, W., Tonelli, J., Kishore, P., Owen, R., Goodman, E., Scherer, P. E., & Hawkins, M. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00312.2006 · Cited by 38
Takagi, H., & Umemoto, T. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.11.071 · Cited by 18
Adiponectina e baixo risco cardiometabólico em obesas
Costa, M. C., Brito, L. L., Barbosa, P. J. B., & Lessa, Í. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000200007 · Cited by 8 · cited 9×
“76 rev assoC Med bras 2015; 61(1):72-80 The main role of adiponectin in vascular physiology is to modulate the cross-link between endothelial cells, smooth muscle cells, leukocytes, and platelets, and protect against vascular injury and atherogenesis.”
BackgroundInfluential
Cited by
Pro-inflammatory cytokines: The link between obesity and osteoarthritis
Wang, T., & He, C. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.10.002 · Cited by 1,034
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882
Cardiovascular risk and obesity
Cercato, C., & Fonseca, F. A. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0468-0 · Cited by 395
Adiponectin, lipids and atherosclerosis
Katsiki, N., Mantzoros, C., & Mikhailidis, D. P. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000431 · Cited by 170
Metadata
- Authors
- Balsan, G. A., Vieira, J. L. D. C., Oliveira, A. M. D., & Portal, V. L.
- Venue
- Revista da Associação Médica Brasileira
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2015-02
- Volume
- 61
- Issue
- 1
- Pages
- 72-80
- ISSN
- 0004-5241 (ISSN-L)
- 0104-4230
- OpenAlex
- W2062736591
- Cited by
- 196
- References
- 42
- FWCI
- 13.07
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.